Loading...
Loading...
India's atenolol imports from CZECH REPUBLIC total $772 across 5 shipments from 1 foreign suppliers. TEVA CZECH INDUSTRIES S.R.O. leads with $772 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include WATSON PHARMA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for atenolol — a concentrated sourcing relationship with select suppliers from CZECH REPUBLIC.

TEVA CZECH INDUSTRIES S.R.O. is the leading Atenolol supplier from CZECH REPUBLIC to India, with import value of $772 across 5 shipments. The top 5 suppliers — TEVA CZECH INDUSTRIES S.R.O. — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TEVA CZECH INDUSTRIES S.R.O. | $772 | 5 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | WATSON PHARMA PRIVATE LIMITED | $772 | 5 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Atenolol suppliers from CZECH REPUBLIC to India include TEVA CZECH INDUSTRIES S.R.O.. The leading supplier is TEVA CZECH INDUSTRIES S.R.O. with import value of $772 USD across 5 shipments. India imported Atenolol worth $772 USD from CZECH REPUBLIC in total across 5 shipments.
India imported Atenolol worth $772 USD from CZECH REPUBLIC across 5 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Atenolol sourced from CZECH REPUBLIC include WATSON PHARMA PRIVATE LIMITED. The largest buyer is WATSON PHARMA PRIVATE LIMITED with $772 in imports across 5 shipments.
The total value of Atenolol imports from CZECH REPUBLIC to India is $772 USD, across 5 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists